YOUR CRO PARTNER CAN HAVE A SIGNIFICANT IMPACT ON THE SUCCESS OR FAILURE OF YOUR CLINICAL STUDY AND PROGRAM.
As a full-service CRO, Worldwide Clinical Trials has an outstanding track record in starting up and executing MS studies, including beta-interferons, glatiramer acetate monoclonal antibodies, and oral preparations for disease-modifying approaches.
SPECIALIZATION IN MS PROGRAMS FOR ACCELERATED TRIALS
When timing is critical and everyday delays can cost millions, Worldwide’s simple, thorough, streamlined operations are critical to your neurology development program.
Whether your study is a small, focused single-region trial or a study that requires global reach, we designed our specialty MS team – neurologists; experienced clinical monitors and project managers; and regulatory, data management, statistical, scientific, and medical experts – to work collaboratively with you to help you overcome the high-risk, high-cost, time-intensive challenges of MS drug development.